U.S. markets open in 3 hours 59 minutes

Skye Bioscience, Inc. (SKYE)

NasdaqGM - NasdaqGM Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
11.61-0.04 (-0.34%)
Al cierre: 04:00PM EDT
11.61 0.00 (0.00%)
Fuera de horario: 04:00PM EDT
Accionistas principales
Nómina de miembros de la gerencia

Transacciones de miembros de la gerencia

Divisa en USD
Compras de miembros de la gerencia en los últimos 6 mesesAccionesTrans
Compras00
VentasN/D0
Acciones netas compradas (vendidas)00
Acciones totales pertenecientes a miembros de la gerencia1.99MN/D
Acciones netas compradas (vendidas) en %N/DN/D
Compras institucionales netas del trimestre anterior al últimoAcciones
Acciones netas compradas (vendidas)N/D
Cambio en acciones institucionales propias en %N/D

Información confidencial de transacciones reportada (últimos dos años)

Miembro de la gerenciaTransacciónTipoValorFechaAcciones

SCHWAB ANDREW J
Director and Beneficial Owner of more than 10% of a Class of Security

Stock Award(Grant) at price 10.00 per share.Indirecto4,500,00013 mar 2024450,000

5AM PARTNERS VII, LLC
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 10.00 per share.Indirecto4,500,00013 mar 2024450,000

GRAYSON PAUL A
Director

Directo29 feb 2024100,000

DHILLON PUNIT S
Chief Executive Officer

Directo29 feb 2024100,000

ARSENAULT KAITLYN MELANIE
Chief Financial Officer

Directo29 feb 202425,000

DIEP TUAN TU
Officer

Directo29 feb 202425,000

SCHWAB ANDREW J
Director and Beneficial Owner of more than 10% of a Class of Security

Stock Award(Grant) at price 2.31 per share.Indirecto12,026,03131 ene 20245,206,074

5AM PARTNERS VII, LLC
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 2.31 per share.Indirecto12,026,03131 ene 20245,206,074

GRAYSON PAUL A
Director

Directo06 nov 2023173,721

DHILLON PUNIT S
Chief Executive Officer

Directo06 nov 2023194,270

ARSENAULT KAITLYN MELANIE
Chief Financial Officer

Directo06 nov 2023128,209

DHILLON PUNIT S
Chief Executive Officer

Purchase at price 0.01 - 0.02 per share.Directo18,46229 ago 20231,000,000

DHILLON PUNIT S
Chief Executive Officer

Purchase at price 0.01 - 0.02 per share.Directo18,44129 ago 20231,000,000

GRAYSON PAUL A
Director

Stock Award(Grant) at price 0.00 per share.Directo025 ago 202318,132,596

DHILLON PUNIT S
Chief Executive Officer

Directo25 ago 202320,277,414

DHILLON PUNIT S
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Directo025 ago 202320,277,414

ARSENAULT KAITLYN MELANIE
Chief Financial Officer

Stock Award(Grant) at price 0.00 per share.Directo025 ago 202313,382,118

EMERALD HEALTH SCIENCES, INC.
Beneficial Owner of more than 10% of a Class of Security

Stock Award(Grant) at price 0.02 - 0.04 per share.Directo1,880,14122 feb 202358,020,650

DHILLON PUNIT S
Chief Executive Officer

Indirecto10 nov 20223,742,264

RAI SUKHWINDER SINGH
Director

Indirecto10 nov 202295,718

DHILLON PUNIT S
Chief Executive Officer

Directo14 dic 20212,000,000

ARSENAULT KAITLYN MELANIE
Chief Financial Officer

Directo14 dic 20211,000,000

HEPPELL JAMES LESLIE
Director

Purchase at price 0.04 per share.Directo22,25007 ago 2020500,000

DHILLON PUNIT S
Chief Executive Officer

Purchase at price 0.04 per share.Directo44,50007 ago 20201,000,000

EMERALD HEALTH SCIENCES, INC.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 0.04 per share.Directo133,50007 ago 20203,000,000

EMERALD HEALTH SCIENCES, INC.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 0.04 per share.Directo114,21707 ago 20202,566,666

EMERALD HEALTH SCIENCES, INC.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 0.04 per share.Directo114,21707 ago 20202,566,666

CESARIO DOUGLAS A
Chief Financial Officer

Stock Award(Grant) at price 0.00 per share.Directo023 jul 2018643,501

EMERALD HEALTH SCIENCES, INC.
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 0.10 per share.Directo3,233,50029 mar 201832,335,000

EMERALD HEALTH SCIENCES, INC.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 0.30 per share.Directo4,462,50016 feb 201815,000,000

EMERALD HEALTH SCIENCES, INC.
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 0.00 per share.Directo1,78124 ene 20181,781,250

LYKOS COSMAS N
Chairman of the Board

Stock Award(Grant) at price 0.00 per share.Directo018 ene 2018900,000

BERECZ ELIZABETH M
Chief Financial Officer

Stock Award(Grant) at price 0.00 per share.Directo018 ene 2018700,000

MURPHY BRIAN STUART
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Directo018 ene 2018900,000

GEORGE THOMAS A
Director

Stock Award(Grant) at price 0.00 per share.Directo020 oct 201560,000

LYKOS COSMAS N
Chairman of the Board

Stock Award(Grant) at price 0.00 per share.Directo020 oct 2015325,000

BERECZ ELIZABETH M
Chief Financial Officer

Stock Award(Grant) at price 0.00 per share.Directo020 oct 2015350,000

INGRAM DOUGLAS S
Officer and Director

Stock Award(Grant) at price 0.00 per share.Directo020 oct 201560,000

GEORGE THOMAS
Director

Stock Award(Grant) at price 0.00 per share.Directo020 oct 201560,000

MCLAUGHLIN GERALD W
Director

Stock Award(Grant) at price 0.00 per share.Directo020 oct 201530,000

MURPHY BRIAN STUART
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Directo020 oct 2015375,000

INGRAM DOUGLAS S
Officer and Director

Conversion of Exercise of derivative security at price 0.00 per share.Directo020 ago 2015312,500

MCLAUGHLIN GERALD W
Director

Conversion of Exercise of derivative security at price 0.00 per share.Directo020 ago 201531,250

LADIN BRIAN D
Beneficial Owner of more than 10% of a Class of Security

Sale at price 4.69 - 4.93 per share.Indirecto241,88510 abr 201550,630